Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Phase 2
- Conditions
- Stroke
- Interventions
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Jacobs Neurological Institute
- Target Recruit Count
- 90
- Registration Number
- NCT01455935
- Locations
- 🇺🇸
Millard Fillmore Gates Circle Hospital, Buffalo, New York, United States
News
No news found